Evolución de mortalidad, abandono, traslado y retención a corto, mediano y largo plazo en pacientes con infección por VIH: Fundación Arriarán 1990-2015

Background: The HIV epidemic reached Chile in late 1980s and as an early response, AIDS care centers were organized. Fundación Arriarán (FA) was the first center. Free antiretroviral therapy (ART) was later provided with progressive coverage and complexity over the years. Aim: To quantify evolutio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cortés,Claudia P., Lizana,Danae, Northland,Rebeca, Wolff R.,Marcelo
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2018
Materias:
HIV
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000300290
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872018000300290
record_format dspace
spelling oai:scielo:S0034-988720180003002902018-06-20Evolución de mortalidad, abandono, traslado y retención a corto, mediano y largo plazo en pacientes con infección por VIH: Fundación Arriarán 1990-2015Cortés,Claudia P.Lizana,DanaeNorthland,RebecaWolff R.,Marcelo Cohort Studies HIV Lost to Follow-Up Mortality Survival Background: The HIV epidemic reached Chile in late 1980s and as an early response, AIDS care centers were organized. Fundación Arriarán (FA) was the first center. Free antiretroviral therapy (ART) was later provided with progressive coverage and complexity over the years. Aim: To quantify evolution of mortality, retention and loss to follow up (LTFU) over 25 years according to different periods of access to ART, from no availability to full coverage with current drugs at FA center. Material and Methods: Retrospective analysis of FA database of 5,080 adults admitted between 1990 and 2014. The sample was distributed in 7 groups: A: no ART (1990-92), B: monotherapy, C: dual therapy, D: dual/triple ART, E: early triple therapy with incomplete coverage, F same as E but with complete coverage and G: contemporary ART (2008-14). Mortality, retention and LTFU were evaluated at 1, 3, 5, 7 and 10 years and at 31/12/2015. Results: Mortality varied from 40% to 2%, and 62% to 7% at 1 and 5 years, for groups A and G respectively; from 71% to 16% at 10 years for groups A and E, respectively. Retention at 5 years were 28%, 23%, 39%, 62%, 75%, 75% and 77% for groups A to G, respectively. LTFU was 10%, 19%, 15%, 17%, 9% 12% and 10% at 5 years for same groups, respectively. At 12/31/2015 22% of patients had died, 11% were LTFU, 60% were retained in care and 6% had been transferred. Conclusions: There is a marked reduction in mortality and increase in retention of HIV patients’ concomitant to expanded access to modern therapy, although LTFU remains a problem.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.146 n.3 20182018-03-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000300290es10.4067/s0034-98872018000300290
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Cohort Studies
HIV
Lost to Follow-Up
Mortality
Survival
spellingShingle Cohort Studies
HIV
Lost to Follow-Up
Mortality
Survival
Cortés,Claudia P.
Lizana,Danae
Northland,Rebeca
Wolff R.,Marcelo
Evolución de mortalidad, abandono, traslado y retención a corto, mediano y largo plazo en pacientes con infección por VIH: Fundación Arriarán 1990-2015
description Background: The HIV epidemic reached Chile in late 1980s and as an early response, AIDS care centers were organized. Fundación Arriarán (FA) was the first center. Free antiretroviral therapy (ART) was later provided with progressive coverage and complexity over the years. Aim: To quantify evolution of mortality, retention and loss to follow up (LTFU) over 25 years according to different periods of access to ART, from no availability to full coverage with current drugs at FA center. Material and Methods: Retrospective analysis of FA database of 5,080 adults admitted between 1990 and 2014. The sample was distributed in 7 groups: A: no ART (1990-92), B: monotherapy, C: dual therapy, D: dual/triple ART, E: early triple therapy with incomplete coverage, F same as E but with complete coverage and G: contemporary ART (2008-14). Mortality, retention and LTFU were evaluated at 1, 3, 5, 7 and 10 years and at 31/12/2015. Results: Mortality varied from 40% to 2%, and 62% to 7% at 1 and 5 years, for groups A and G respectively; from 71% to 16% at 10 years for groups A and E, respectively. Retention at 5 years were 28%, 23%, 39%, 62%, 75%, 75% and 77% for groups A to G, respectively. LTFU was 10%, 19%, 15%, 17%, 9% 12% and 10% at 5 years for same groups, respectively. At 12/31/2015 22% of patients had died, 11% were LTFU, 60% were retained in care and 6% had been transferred. Conclusions: There is a marked reduction in mortality and increase in retention of HIV patients’ concomitant to expanded access to modern therapy, although LTFU remains a problem.
author Cortés,Claudia P.
Lizana,Danae
Northland,Rebeca
Wolff R.,Marcelo
author_facet Cortés,Claudia P.
Lizana,Danae
Northland,Rebeca
Wolff R.,Marcelo
author_sort Cortés,Claudia P.
title Evolución de mortalidad, abandono, traslado y retención a corto, mediano y largo plazo en pacientes con infección por VIH: Fundación Arriarán 1990-2015
title_short Evolución de mortalidad, abandono, traslado y retención a corto, mediano y largo plazo en pacientes con infección por VIH: Fundación Arriarán 1990-2015
title_full Evolución de mortalidad, abandono, traslado y retención a corto, mediano y largo plazo en pacientes con infección por VIH: Fundación Arriarán 1990-2015
title_fullStr Evolución de mortalidad, abandono, traslado y retención a corto, mediano y largo plazo en pacientes con infección por VIH: Fundación Arriarán 1990-2015
title_full_unstemmed Evolución de mortalidad, abandono, traslado y retención a corto, mediano y largo plazo en pacientes con infección por VIH: Fundación Arriarán 1990-2015
title_sort evolución de mortalidad, abandono, traslado y retención a corto, mediano y largo plazo en pacientes con infección por vih: fundación arriarán 1990-2015
publisher Sociedad Médica de Santiago
publishDate 2018
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000300290
work_keys_str_mv AT cortesclaudiap evoluciondemortalidadabandonotrasladoyretencionacortomedianoylargoplazoenpacientesconinfeccionporvihfundacionarriaran19902015
AT lizanadanae evoluciondemortalidadabandonotrasladoyretencionacortomedianoylargoplazoenpacientesconinfeccionporvihfundacionarriaran19902015
AT northlandrebeca evoluciondemortalidadabandonotrasladoyretencionacortomedianoylargoplazoenpacientesconinfeccionporvihfundacionarriaran19902015
AT wolffrmarcelo evoluciondemortalidadabandonotrasladoyretencionacortomedianoylargoplazoenpacientesconinfeccionporvihfundacionarriaran19902015
_version_ 1718436994243100672